“…However, the mechanisms of this process are still unclear. Moreover, research on paw edema inhibition has demonstrated that the activation of PPAR␥ receptors may also contribute to antiangiogenic action of its ligands (agonists), which, once activated, inhibit angiogenesis through the modulation of cytokines [6,7].…”